BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19401003)

  • 61. The effect of follicular antimullerian hormone levels of non-obese, non-hyperandrogenemic polycystic ovary syndrome patients on assisted reproduction outcome.
    Yilmaz N; Uygur D; Dogan M; Ozgu E; Salman B; Mollamahmutoglu L
    Gynecol Endocrinol; 2012 Mar; 28(3):162-5. PubMed ID: 22103791
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Do endometriomas induce an inflammatory reaction in nearby follicles?
    Opøien HK; Fedorcsak P; Polec A; Stensen MH; Åbyholm T; Tanbo T
    Hum Reprod; 2013 Jul; 28(7):1837-45. PubMed ID: 23543385
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Interleukin-1 beta, interleukin-6, and growth hormone levels in human follicular fluid.
    Huyser C; Fourie FL; Bosmans E; Levay PF
    J Assist Reprod Genet; 1994 Apr; 11(4):193-202. PubMed ID: 7711382
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Differential expression of follicular fluid cytokines: relationship to subsequent pregnancy in IVF cycles.
    Bedaiwy M; Shahin AY; AbulHassan AM; Goldberg JM; Sharma RK; Agarwal A; Falcone T
    Reprod Biomed Online; 2007 Sep; 15(3):321-5. PubMed ID: 17854532
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.
    Kunt C; Ozaksit G; Keskin Kurt R; Cakir Gungor AN; Kanat-Pektas M; Kilic S; Dede A
    Arch Gynecol Obstet; 2011 Jun; 283(6):1415-21. PubMed ID: 21562964
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Granulocyte colony-stimulating factor: A relation between serum and follicular fluid levels and in-vitro fertilization outcome in patients with polycystic ovary syndrome.
    Kahyaoglu I; Yılmaz N; Timur H; Inal HA; Erkaya S
    Cytokine; 2015 Jul; 74(1):113-6. PubMed ID: 25258001
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Ovarian reserve and PGD treatment outcome in women with myotonic dystrophy.
    Srebnik N; Margalioth EJ; Rabinowitz R; Varshaver I; Altarescu G; Renbaum P; Levi-Lahad E; Weintraub A; Eldar-Geva T
    Reprod Biomed Online; 2014 Jul; 29(1):94-101. PubMed ID: 24813161
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Which cut-off value of serum anti-Müllerian hormone level can predict poor ovarian reserve, poor ovarian response to stimulation and in vitro fertilization success? A prospective data analysis.
    Ficicioglu C; Cenksoy PO; Yildirim G; Kaspar C
    Gynecol Endocrinol; 2014 May; 30(5):372-6. PubMed ID: 24576292
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles.
    Ferrari B; Pezzuto A; Barusi L; Coppola F
    Eur J Obstet Gynecol Reprod Biol; 2006 Jan; 124(1):70-6. PubMed ID: 16183188
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison between cytokine concentration in follicular fluid of poor and high responder patients and their influence of ICSI-outcome.
    Hammadeh ME; Fischer-Hammadeh C; Georg T; Rosenbaum P; Schmidt W
    Am J Reprod Immunol; 2003 Aug; 50(2):131-6. PubMed ID: 12846676
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The level of vitamin D in follicular fluid and ovarian reserve in an in vitro fertilization program: A pilot study.
    Han JY; Kim SW; Kim H; Ku SY
    Sci Prog; 2022; 105(2):368504221103782. PubMed ID: 35619572
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Serum and follicular fluid hormone levels during in vitro fertilization after short- or long-course treatment with a gonadotropin-releasing hormone agonist.
    Bo-Abbas YY; Martin KA; Liberman RF; Cramer DW; Barbieri RL
    Fertil Steril; 2001 Apr; 75(4):694-9. PubMed ID: 11287021
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Clinical relevance of combined FSH and AMH observations in infertile women.
    Gleicher N; Kim A; Kushnir V; Weghofer A; Shohat-Tal A; Lazzaroni E; Lee HJ; Barad DH
    J Clin Endocrinol Metab; 2013 May; 98(5):2136-45. PubMed ID: 23533225
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Vitamin D and anti-Müllerian hormone concentration in human follicular fluid individually aspirated from all patient follicles.
    Skowrońska P; Kunicki M; Pastuszek E; Konieczna L; Bączek T; Męczekalski B; Smolarczyk R; Łukaszuk K
    Gynecol Endocrinol; 2022 Jan; 38(1):28-32. PubMed ID: 34044669
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Anti-Müllerian hormone and polycystic ovary syndrome: assessment of the clinical pregnancy rates in in vitro fertilization patients.
    Sahmay S; Guralp O; Aydogan B; Cepni I; Oral E; Irez T
    Gynecol Endocrinol; 2013 May; 29(5):440-3. PubMed ID: 23461296
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum anti-Müllerian hormone (AMH) levels are differentially modulated by both serum gonadotropins and not only by serum follicle stimulating hormone (FSH) levels.
    Panidis D; Katsikis I; Karkanaki A; Piouka A; Armeni AK; Georgopoulos NA
    Med Hypotheses; 2011 Oct; 77(4):649-53. PubMed ID: 21807466
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Utility of age-specific serum anti-Müllerian hormone concentrations.
    Barad DH; Weghofer A; Gleicher N
    Reprod Biomed Online; 2011 Mar; 22(3):284-91. PubMed ID: 21269880
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Concentrations of anti-Müllerian hormone in fluid from small human antral follicles show a negative correlation with CYP19 mRNA expression in the corresponding granulosa cells.
    Eilsø Nielsen M; Rasmussen IA; Fukuda M; Westergaard LG; Yding Andersen C
    Mol Hum Reprod; 2010 Sep; 16(9):637-43. PubMed ID: 20064870
    [TBL] [Abstract][Full Text] [Related]  

  • 80. What are the likely IVF/ICSI outcomes if there is a discrepancy between serum AMH and FSH levels? A multicenter retrospective study.
    Daney de Marcillac F; Pinton A; Guillaume A; Sagot P; Pirrello O; Rongieres C
    J Gynecol Obstet Hum Reprod; 2017 Oct; 46(8):629-635. PubMed ID: 28843783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.